During the past decade, Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 2 trials sponsored, "National Cancer Institute, Naples" with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" are "Breast Cancer" (2 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials), "Advanced Stage IIIB" (1 trials), "Breast Cancer Recurrent" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" in a lesser frequency.

Most popular intervention types in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" are "Drug" (14 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "Pemetrexed" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".